tickdelta
tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

CVSCVS Health

Health care · Pharmacies · NYSE
CVS quote by TradingView
Employees
300,000
Headquarters
Woonsocket, RI
CEO
J. David Joyner
Next results
around Feb 9, 2027
Compare with peers → Embed
All key numbers (42, from the latest 10-K and 10-Q) From EDGAR
EPS (ttm)8.61Sales (ttm)420.6BNet income (ttm)11.0BSales growth+7.8%EPS growth-62.0%Sales Q/Q+5.4%
Free cash flow15.6BGross margin44.2%Oper. margin3.6%Net margin2.6%FCF margin3.7%ROE13.7%
ROA4.3%R&D / sales-Dividend2.66Debt/Eq0.75Curr. ratio0.85Cash11.7B
Op. cash flow (ttm)18.7BEBITDA9.3BEBITDA margin2.3%Net debt48.9BQuick ratio0.65Interest cover1.49
ROIC2.7%Payout ratio191.4%Tax rate19.1%Stock pay / sales0.1%Shares out.1.3BShares Y/Y+0.7%
Book / share62.91Cash / share9.17Sales / share328.74Asset turnover1.63Inventory turns11.49Days sales out.36
Sales 3Y CAGR+7.6%Sales 5Y CAGR+8.4%EPS 3Y CAGR-24.7%EPS 5Y CAGR-23.9%Employees300,000Sales / employee1.4M

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

CVS against Health care peers

Ten years, side by side → · All 60 →
GrowthProfitBalanceCleanInsiders
CVSPeer median

Each side 0 to 100, ranked against every company we cover: relative position on reported figures, not a buy score. How

Every dot is one of the 60 companies, the better end on the right. Hover a dot for the company.

Sales growth
+7.8%28th of 60 · median +7.1%
Net margin
2.6%47th of 60 · median 9.6%
Return on equity
13.7%24th of 54 · median 13.1%
Free cash flow margin
3.7%48th of 56 · median 15.5%
Debt / equity (less is better)
0.7534th of 49 · median 0.66
CVS and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthGross marginNet marginROEFCF marginDebt / equity
CVS CVS Health$420.6B +7.8%44.2%2.6%13.7%3.7%0.75
UNH UnitedHealth Group$449.7B +11.8%88.3%3.5%15.3%5.1%0.71
MCK McKesson$418.8B +12.4%3.7%1.1%-1.7%-
COR Cencora$332.8B +9.3%4.0%0.8%86.0%1.2%3.93
CI Cigna$286.3B +11.2%20.7%2.1%13.8%-0.68
CAH Cardinal Health$257.8B +14.2%3.9%0.7%-1.9%-

From $292.1B of sales to $8.0B of profit

FY2021, from the 10-K income statement
Revenue to Gross profit: $116.3BRevenue to Cost of revenue: $175.8BGross profit to Operating profit: $13.3BGross profit to Operating expenses: $103.0BOperating profit to Net profit: $8.0BOperating profit to Tax & other: $5.3B Revenue: $292.1B Revenue$292.1B +9% Y/Y Gross profit: $116.3B · 40% margin Gross profit$116.3B40% margin Cost of revenue: $175.8B · 60% of revenue Cost of revenue$175.8B60% of revenue Operating profit: $13.3B · 5% margin Operating profit$13.3B5% margin −4% Y/Y Operating expenses: $103.0B · 35% of revenue Operating expenses$103.0B35% of revenue Net profit: $8.0B · 3% margin Net profit$8.0B3% margin +11% Y/Y Tax & other: $5.3B · 2% of revenue Tax & other$5.3B2% of revenue

Swipe sideways for the whole flow →

From $322.5B of sales to $4.3B of profit

FY2022, from the 10-K income statement
Revenue to Gross profit: $125.6BRevenue to Cost of revenue: $196.9BGross profit to Operating profit: $8.0BGross profit to Operating expenses: $117.6BOperating profit to Net profit: $4.3BOperating profit to Tax & other: $3.6B Revenue: $322.5B Revenue$322.5B +10% Y/Y Gross profit: $125.6B · 39% margin Gross profit$125.6B39% margin Cost of revenue: $196.9B · 61% of revenue Cost of revenue$196.9B61% of revenue Operating profit: $8.0B · 2% margin Operating profit$8.0B2% margin −40% Y/Y Operating expenses: $117.6B · 36% of revenue Operating expenses$117.6B36% of revenue Net profit: $4.3B · 1% margin Net profit$4.3B1% margin −46% Y/Y Tax & other: $3.6B · 1% of revenue Tax & other$3.6B1% of revenue

Swipe sideways for the whole flow →

From $357.8B of sales to $8.3B of profit

FY2023, from the 10-K income statement
Revenue to Gross profit: $140.7BRevenue to Cost of revenue: $217.1BGross profit to Operating profit: $13.7BGross profit to Operating expenses: $126.9BOperating profit to Net profit: $8.3BOperating profit to Tax & other: $5.4B Revenue: $357.8B Revenue$357.8B +11% Y/Y Gross profit: $140.7B · 39% margin Gross profit$140.7B39% margin Cost of revenue: $217.1B · 61% of revenue Cost of revenue$217.1B61% of revenue Operating profit: $13.7B · 4% margin Operating profit$13.7B4% margin +73% Y/Y Operating expenses: $126.9B · 35% of revenue Operating expenses$126.9B35% of revenue Net profit: $8.3B · 2% margin Net profit$8.3B2% margin +94% Y/Y Tax & other: $5.4B · 2% of revenue Tax & other$5.4B2% of revenue

Swipe sideways for the whole flow →

From $372.8B of sales to $4.6B of profit

FY2024, from the 10-K income statement
Revenue to Gross profit: $166.5BRevenue to Cost of revenue: $206.3BGross profit to Operating profit: $8.5BGross profit to Operating expenses: $158.0BOperating profit to Net profit: $4.6BOperating profit to Tax & other: $3.9B Revenue: $372.8B Revenue$372.8B +4% Y/Y Gross profit: $166.5B · 45% margin Gross profit$166.5B45% margin Cost of revenue: $206.3B · 55% of revenue Cost of revenue$206.3B55% of revenue Operating profit: $8.5B · 2% margin Operating profit$8.5B2% margin −38% Y/Y Operating expenses: $158.0B · 42% of revenue Operating expenses$158.0B42% of revenue Net profit: $4.6B · 1% margin Net profit$4.6B1% margin −45% Y/Y Tax & other: $3.9B · 1% of revenue Tax & other$3.9B1% of revenue

Swipe sideways for the whole flow →

From $402.1B of sales to $1.8B of profit

FY2025, from the 10-K income statement
Revenue to Gross profit: $180.9BRevenue to Cost of revenue: $221.2BGross profit to Operating profit: $4.7BGross profit to Operating expenses: $176.2BOperating profit to Net profit: $1.8BOperating profit to Tax & other: $2.9B Revenue: $402.1B Revenue$402.1B +8% Y/Y Gross profit: $180.9B · 45% margin Gross profit$180.9B45% margin Cost of revenue: $221.2B · 55% of revenue Cost of revenue$221.2B55% of revenue Operating profit: $4.7B · 1% margin Operating profit$4.7B1% margin −45% Y/Y Operating expenses: $176.2B · 44% of revenue Operating expenses$176.2B44% of revenue Net profit: $1.8B · 0% margin Net profit$1.8B0% margin −62% Y/Y Tax & other: $2.9B · 1% of revenue Tax & other$2.9B1% of revenue

Swipe sideways for the whole flow →

Where each $100 of sales went

FY2021
FY2022
FY2023
FY2024
FY2025
  • Cost of revenue
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement →

Profitability

0 of 3
  • !
    Net margin below the peer median2.6% vs 9.6%
  • !
    Return on equity below 15%13.7%
  • !
    A profit in 9 of 10 years
Net margin, FY2016 to FY2025: 3.0% → 0.4%

Balance sheet

1 of 4
  • !
    Interest covered less than 5 timesOperating income is 1.5× interest expense
  • ✓
    Debt smaller than equityDebt / equity 0.75 on the latest balance sheet (peer median 0.66)
  • !
    Current ratio below 1Current ratio 0.85
  • !
    Net debt over 3 years of free cash flow$46.8B net debt, 3.0 years
Debt / equity at each year end, FY2016 to FY2025: 0.75 → 0.86
What the debt is made of ↓

Cash and shareholders

4 of 4
  • ✓
    Free cash flow positive in every one of 10 years$7.8B last year
  • ✓
    Share count down over 5 years−3.3%
  • ✓
    Dividend per share up over 5 years$2.00 → $2.66
  • ✓
    Cash from operations above net income$10.6B vs $1.8B
Free cash flow, FY2016 to FY2025: 7.9B → 7.8B

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

What the debt is made of, and when it is due

balance sheet of Sep 30, 2026 · schedule of Dec 31, 2025
Debt: $60.7B Debt$60.7B Long-term debt: $57.2B · 90% Long-term debt$57.2B · 90% Due within a year: $3.5B · 5% Due within a year$3.5B · 5% Next 12 months: $4.0B · 6% Next 12 months$4.0B · 6% Year 2: $3.4B · 5% Year 2$3.4B · 5% Year 3: $5.0B · 8% Year 3$5.0B · 8% Year 4: $3.8B · 6% Year 4$3.8B · 6% Year 5: $4.3B · 7% Year 5$4.3B · 7% After year 5: $43.3B · 68% After year 5$43.3B · 68%

The debt note's own lines, 2025-12-31

Line, as the company names itKindRateFixed or floatingAmount
5.05% senior notes due March 2048 (Senior Notes)Notes and bonds5.05%not stated$8.0B
4.3% senior notes due March 2028 (Senior Notes)Notes and bonds4.30%not stated$5.0B
4.78% senior notes due March 2038 (Senior Notes)Notes and bonds4.78%not stated$5.0B
5.125% senior notes due July 2045 (Senior Notes)Notes and bonds5.12%not stated$3.5B
1.3% senior notes due August 2027 (Senior Notes)Notes and bonds1.30%not stated$2.2B
7% series A junior subordinated notes due March 2055 (Junior Subordinated Debt)Subordinated7.00%not stated$2.2B
2.875% senior notes due June 2026 (Senior Notes)Notes and bonds2.88%not stated$1.8B
3.25% senior notes due August 2029 (Senior Notes)Notes and bonds3.25%not stated$1.8B
5.25% senior notes due February 2033 (Senior Notes)Notes and bonds5.25%not stated$1.8B
3.75% senior notes due April 2030 (Senior Notes)Notes and bonds3.75%not stated$1.5B
5% senior notes due February 2026 (Senior Notes)Notes and bonds5.00%not stated$1.5B
5.125% senior notes due February 2030 (Senior Notes)Notes and bonds5.12%not stated$1.5B
5.45% senior notes due September 2035 (Senior Notes)Notes and bonds5.45%not stated$1.5B
1.875% senior notes due February 2031 (Senior Notes)Notes and bonds1.88%not stated$1.2B
1.75% senior notes due August 2030 (Senior Notes)Notes and bonds1.75%not stated$1.2B
5.3% senior notes due June 2033 (Senior Notes)Notes and bonds5.30%not stated$1.2B
5.625% senior notes due February 2053 (Senior Notes)Notes and bonds5.62%not stated$1.2B
5.7% senior notes due June 2034 (Senior Notes)Notes and bonds5.70%not stated$1.2B
5.875% senior notes due June 2053 (Senior Notes)Notes and bonds5.88%not stated$1.2B
6.2% senior notes due September 2055 (Senior Notes)Notes and bonds6.20%not stated$1.2B
2.125% senior notes due September 2031 (Senior Notes)Notes and bonds2.12%not stated$1.0B
5.4% senior notes due June 2029 (Senior Notes)Notes and bonds5.40%not stated$1.0B
5.55% senior notes due June 2031 (Senior Notes)Notes and bonds5.55%not stated$1.0B
5% senior notes due January 2029 (Senior Notes)Notes and bonds5.00%not stated$1.0B
6.05% senior notes due June 2054 (Senior Notes)Notes and bonds6.05%not stated$1.0B
6.625% senior notes due June 2036 (Senior Notes)Notes and bonds6.62%not stated$771.0M
3.625% senior notes due April 2027 (Senior Notes)Notes and bonds3.62%not stated$750.0M
3% senior notes due August 2026 (Senior Notes)Notes and bonds3.00%not stated$750.0M
5.25% senior notes due January 2031 (Senior Notes)Notes and bonds5.25%not stated$750.0M
5.3% senior notes due December 2043 (Senior Notes)Notes and bonds5.30%not stated$750.0M
5% senior notes due September 2032 (Senior Notes)Notes and bonds5.00%not stated$750.0M
6% senior notes due June 2044 (Senior Notes)Notes and bonds6.00%not stated$750.0M
6% senior notes due June 2063 (Senior Notes)Notes and bonds6.00%not stated$750.0M
6.75% series B junior subordinated notes due December 2054 (Junior Subordinated Debt)Subordinated6.75%not stated$750.0M
4.875% senior notes due July 2035 (Senior Notes)Notes and bonds4.88%not stated$652.0M
4.125% senior notes due April 2040 (Senior Notes)Notes and bonds4.12%not stated$602.0M
3.875% senior notes due August 2047 (Senior Notes)Notes and bonds3.88%not stated$537.0M
6.75% senior notes due December 2037 (Senior Notes)Notes and bonds6.75%not stated$533.0M
4.5% senior notes due May 2042 (Senior Notes)Notes and bonds4.50%not stated$500.0M
6.25% senior notes due September 2065 (Senior Notes)Notes and bonds6.25%not stated$500.0M
6.125% senior notes due September 2039 (Senior Notes)Notes and bonds6.12%not stated$447.0M
4.25% senior notes due April 2050 (Senior Notes)Notes and bonds4.25%not stated$399.0M
4.75% senior notes due March 2044 (Senior Notes)Notes and bonds4.75%not stated$375.0M
6.25% senior notes due June 2027 (Senior Notes)Notes and bonds6.25%not stated$372.0M
2.7% senior notes due August 2040 (Senior Notes)Notes and bonds2.70%not stated$367.0M
Other Debt Obligations––not stated$295.0M
4.125% senior notes due November 2042 (Senior Notes)Notes and bonds4.12%not stated$226.0M
5.75% senior notes due May 2041 (Senior Notes)Notes and bonds5.75%not stated$133.0M
All 48 lines

From the debt note in the 10-K's XBRL (0000064803-26-000010), as the company tags it: by issue, by year, by currency or by kind. Lines from two ways of cutting the same debt can overlap, so they are not added up. Fixed or floating is read from the line's own name only; "not stated" when it says neither.

Left: the debt lines on the balance sheet (XBRL). Right: the principal due each year, from the debt note's maturity schedule; it can differ a little from the balance sheet, which shows the debt net of discounts and fees. Leases are not counted. The full schedule →

Revenue and net income, FY2016 to FY2025

Revenue 402.1B Net income 1.8B
FY2016 revenue 177.5B · Revenues, 0000064803-19-000013 FY2016 net income 5.3B · NetIncomeLoss, 0000064803-19-000013 177.5B FY2016 FY2017 revenue 184.8B · Revenues, 0000064803-20-000007 FY2017 net income 6.6B · NetIncomeLoss, 0000064803-20-000007 184.8B FY2017 FY2018 revenue 194.6B · Revenues, 0000064803-21-000011 FY2018 net income -594.0M · NetIncomeLoss, 0000064803-21-000011 194.6B FY2018 FY2019 revenue 256.8B · Revenues, 0000064803-22-000008 FY2019 net income 6.6B · NetIncomeLoss, 0000064803-22-000008 256.8B FY2019 FY2020 revenue 268.7B · Revenues, 0000064803-23-000009 FY2020 net income 7.2B · NetIncomeLoss, 0000064803-23-000009 268.7B FY2020 FY2021 revenue 292.1B · Revenues, 0000064803-24-000007 FY2021 net income 8.0B · NetIncomeLoss, 0000064803-24-000007 292.1B FY2021 FY2022 revenue 322.5B · Revenues, 0000064803-25-000007 FY2022 net income 4.3B · NetIncomeLoss, 0000064803-25-000007 322.5B FY2022 FY2023 revenue 357.8B · Revenues, 0000064803-26-000010 FY2023 net income 8.3B · NetIncomeLoss, 0000064803-26-000010 357.8B FY2023 FY2024 revenue 372.8B · Revenues, 0000064803-26-000010 FY2024 net income 4.6B · NetIncomeLoss, 0000064803-26-000010 372.8B FY2024 FY2025 revenue 402.1B · Revenues, 0000064803-26-000010 FY2025 net income 1.8B · NetIncomeLoss, 0000064803-26-000010 402.1B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. Full financials →

CVS's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Annual Quarterly
Revenue402.1B
FY2016: 177.5BFY2017: 184.8BFY2018: 194.6BFY2019: 256.8BFY2020: 268.7BFY2021: 292.1BFY2022: 322.5BFY2023: 357.8BFY2024: 372.8BFY2025: 402.1B FY2017FY2019FY2021FY2023FY2025
Net income1.8B
FY2016: 5.3BFY2017: 6.6BFY2018: -594.0MFY2019: 6.6BFY2020: 7.2BFY2021: 8.0BFY2022: 4.3BFY2023: 8.3BFY2024: 4.6BFY2025: 1.8B FY2017FY2019FY2021FY2023FY2025
Free cash flow7.8B
FY2016: 7.9BFY2017: 6.1BFY2018: 6.8BFY2019: 10.4BFY2020: 13.4BFY2021: 15.7BFY2022: 13.4BFY2023: 10.4BFY2024: 6.3BFY2025: 7.8B FY2017FY2019FY2021FY2023FY2025
EPS (diluted)1.39
FY2016: 4.90FY2017: 6.44FY2018: -0.57FY2019: 5.08FY2020: 5.46FY2021: 6.02FY2022: 3.26FY2023: 6.47FY2024: 3.66FY2025: 1.39 FY2017FY2019FY2021FY2023FY2025
Dividend per share2.66
FY2016: 1.70FY2017: 2.00FY2018: 2.00FY2019: 2.00FY2020: 2.00FY2021: 2.00FY2022: 2.20FY2023: 2.42FY2024: 2.66FY2025: 2.66 FY2017FY2019FY2021FY2023FY2025
Diluted shares1.3B
FY2016: 1.1BFY2017: 1.0BFY2018: 1.0BFY2019: 1.3BFY2020: 1.3BFY2021: 1.3BFY2022: 1.3BFY2023: 1.3BFY2024: 1.3BFY2025: 1.3B FY2017FY2019FY2021FY2023FY2025

Revenue by business segment

year to Dec 31, 2025
RevenueSharevs year before
Health Services 190.4B47.4% +9.7%
Health Care Benefits 143.4B35.7% +9.7%
Pharmacy And Consumer Health 139.4B34.7% +11.9%

10-K 0000064803-26-000010, segment and revenue notes (XBRL).

Revenue by product or service

year to Dec 31, 2025
RevenueSharevs year before
Products 249.9B62.2% +7.9%
Services 15.2B3.8% -6.6%

10-K 0000064803-26-000010, segment and revenue notes (XBRL).

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue177.5B184.8B194.6B256.8B268.7B292.1B322.5B357.8B372.8B402.1B
Cost of revenue148.7B156.2B156.4B158.7B164.0B175.8B196.9B217.1B206.3B221.2B
Gross profit28.9B28.5B--------
Operating income10.4B9.5B4.0B12.0B13.9B13.3B8.0B13.7B8.5B4.7B
Interest expense1.1B1.1B2.6B3.0B2.9B2.5B2.3B2.7B3.0B3.1B
Pretax income8.6B8.3B1.4B9.0B9.8B10.5B5.8B11.2B6.1B2.1B
Income tax3.3B1.6B2.0B2.4B2.6B2.5B1.5B2.8B1.6B408.0M
Net income5.3B6.6B-594.0M6.6B7.2B8.0B4.3B8.3B4.6B1.8B
EPS (diluted)4.906.44-0.575.085.466.023.266.473.661.39
Diluted shares1.1B1.0B1.0B1.3B1.3B1.3B1.3B1.3B1.3B1.3B
Depreciation & amortization2.5B2.5B2.7B4.4B4.4B4.5B4.2B4.4B4.6B4.6B
EBITDA12.9B12.0B6.7B16.4B18.4B17.8B12.2B18.1B13.1B9.3B
Gross margin16.3%15.4%--------
Operating margin5.8%5.2%2.1%4.7%5.2%4.6%2.5%3.8%2.3%1.2%
Net margin3.0%3.6%-0.3%2.6%2.7%2.7%1.3%2.3%1.2%0.4%
Revenue growth-+4.1%+5.3%+32.0%+4.6%+8.7%+10.4%+10.9%+4.2%+7.8%
EPS growth-+31.4%-109%-+7.5%+10.3%-45.8%+98.5%-43.4%-62.0%

Balance sheet

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash3.4B1.7B4.1B5.7B7.9B9.4B12.9B8.2B8.6B8.5B
Short-term investments87.0M111.0M2.5B2.4B3.0B3.1B2.8B3.3B2.4B2.1B
Receivables12.2B13.2B17.6B19.6B21.7B24.4B27.3B35.2B36.5B39.8B
Inventory14.8B15.3B16.4B17.5B18.5B17.8B19.1B18.0B18.1B19.2B
Current assets31.0B31.2B45.2B50.3B56.4B60.0B65.6B67.9B68.6B74.7B
Property & equipment10.2B10.3B11.3B12.0B12.6B12.9B12.9B---
Goodwill38.2B38.5B78.7B79.7B79.6B79.1B78.2B91.3B91.3B85.5B
Total assets94.5B95.1B196.5B222.4B230.7B233.1B228.3B249.7B253.2B253.5B
Accounts payable7.9B8.9B--------
Current liabilities26.2B30.6B44.0B53.3B62.0B67.7B69.4B79.2B84.6B88.7B
Total debt27.6B28.3B74.1B68.5B64.6B56.2B52.3B61.6B66.3B64.6B
Total liabilities-57.4B137.9B158.3B161.0B158.2B156.5B173.1B177.5B178.2B
Shareholders' equity36.8B37.7B58.2B63.9B69.4B74.5B71.5B76.5B75.6B75.2B
Retained earnings39.0B43.6B40.9B45.1B49.6B55.0B56.4B61.6B62.8B61.2B

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow10.1B8.0B8.9B12.8B15.9B18.3B16.2B13.4B9.1B10.6B
Capital spending2.2B1.9B2.0B2.5B2.4B2.5B2.7B3.0B2.8B2.8B
Free cash flow7.9B6.1B6.8B10.4B13.4B15.7B13.4B10.4B6.3B7.8B
Stock-based pay (added back)222.0M234.0M280.0M453.0M400.0M484.0M447.0M588.0M540.0M535.0M
Dividends paid1.8B2.0B2.0B2.6B2.6B2.6B2.9B3.1B3.4B3.4B
Buybacks4.5B4.4B00003.5B2.0B3.0B0
Acquisitions524.0M1.2B42.2B444.0M866.0M146.0M139.0M16.6B95.0M436.0M
Debt raised3.5B044.3B3.7B10.0B987.0M010.9B7.9B4.0B
Debt repaid5.9B05.5B8.3B15.6B10.3B4.2B3.2B4.8B3.6B
Investing cash flow-2.5B-2.9B-43.3B-3.3B-5.5B-5.3B-5.0B-20.9B-7.6B-5.9B
Financing cash flow-6.8B-6.8B36.8B-7.7B-7.7B-11.4B-10.5B2.7B-1.1B-4.9B
Dividend per share1.702.002.002.002.002.002.202.422.662.66

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)222.0M234.0M280.0M453.0M400.0M484.0M447.0M588.0M540.0M535.0M
Stock-based pay / revenue0.1%0.1%0.1%0.2%0.1%0.2%0.1%0.2%0.1%0.1%
Operating lease cost---2.7B2.7B2.6B2.6B2.5B2.4B2.4B
Operating lease cash paid---2.7B2.7B2.7B2.7B2.8B2.7B2.7B
Finance lease principal paid---26.0M34.0M50.0M62.0M70.0M74.0M77.0M
Right-of-use assets--020.9B20.7B19.1B17.9B17.3B15.9B15.0B
Operating lease liabilities--020.5B20.4B19.8B18.5B17.8B16.6B15.4B
Finance lease liabilities---808.0M1.1B1.3B1.5B1.4B1.4B1.3B

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Work on CVS in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CVS/export.csv") into a cell.